RETRACTED ARTICLE: ABCB1 (1199G>A) polymorphism regulates the efficacy of docetaxel and imatinib mesylate in HEK293 recombinant cell lines

Rui Peng, Hong Zhang, Ying Zhang, Dan-yun Wei

Open source

DOI
10.1007/s00280-015-2802-z
Published
2015-06-21
Container
Cancer Chemotherapy and Pharmacology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00280-015-2802-z,
  title = {RETRACTED ARTICLE: ABCB1 (1199G\>A) polymorphism regulates the efficacy of docetaxel and imatinib mesylate in HEK293 recombinant cell lines},
  author = {Rui Peng and Hong Zhang and Ying Zhang and Dan-yun Wei},
  year = {2015},
  journal = {Cancer Chemotherapy and Pharmacology},
  doi = {10.1007/s00280-015-2802-z},
  url = {https://doi.org/10.1007/s00280-015-2802-z}
}

RIS

TY  - JOUR
TI  - RETRACTED ARTICLE: ABCB1 (1199G>A) polymorphism regulates the efficacy of docetaxel and imatinib mesylate in HEK293 recombinant cell lines
AU  - Rui Peng
AU  - Hong Zhang
AU  - Ying Zhang
AU  - Dan-yun Wei
PY  - 2015
JO  - Cancer Chemotherapy and Pharmacology
DO  - 10.1007/s00280-015-2802-z
UR  - https://doi.org/10.1007/s00280-015-2802-z
ER  - 

APA

Peng, R., Zhang, H., Zhang, Y., & Wei, D. (2015). RETRACTED ARTICLE: ABCB1 (1199G>A) polymorphism regulates the efficacy of docetaxel and imatinib mesylate in HEK293 recombinant cell lines. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-015-2802-z

Source records